BRCA1 patent applications on October 3rd, 2024

From WikiPatents
Jump to navigation Jump to search

Patent Applications for BRCA1 on October 3rd, 2024

Number of patent applications containing 'BRCA1' or its variations: 1

Janssen Pharmaceutica NV (20240325369). TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH NIRAPARIB simplified abstract

Organization: Janssen Pharmaceutica NV

Inventor(s): Peter Francis of Raritan NJ (US) for Janssen Pharmaceutica NV, Angela Mennicke LOPEZ-GITLITZ of Los Angeles CA (US) for Janssen Pharmaceutica NV, Natalie A NUTNICK of Norristown PA (US) for Janssen Pharmaceutica NV, Gary Edward MASON of New Hope PA (US) for Janssen Pharmaceutica NV, Xin ZHAO of Foster City CA (US) for Janssen Pharmaceutica NV, Michael P GORMLEY of Mount Laurel NJ (US) for Janssen Pharmaceutica NV, Yuangen ZHU of Towaco NJ (US) for Janssen Pharmaceutica NV, Karen Ann URTISHAK of Media PA (US) for Janssen Pharmaceutica NV, Shibu THOMAS of Lower Gwynedd PA (US) for Janssen Pharmaceutica NV, Adam A Del Corral of River Edge NJ (US) for Janssen Pharmaceutica NV

IPC Code(s): A61K31/454, A61K9/00, A61P35/00

CPC Code(s): A61K31/454

Retrieved from "http://wikipatents.org/index.php?title=BRCA1_patent_applications_on_October_3rd,_2024&oldid=246846"